Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
British Journal of Cancer
|
February 23, 2012
Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality
T L Jørgensen, J Hallas, S Friis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 10, 2016
MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update
A Molassiotis, M Aapro, J Herrstedt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy
T Sigsgaard, J Herrstedt, J Handberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)
J Herrstedt, M S Aapro, F Roila, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 2, 2000
Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy
T Sigsgaard, J Herrstedt, P Christensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2014
Bone health in cancer patients: ESMO Clinical Practice Guidelines
R Coleman, J J Body, M Aapro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 18, 1998
Corticosteroids, dopamine antagonists and other drugs
J Herrstedt, M S Aapro, J F Smyth, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 12, 1998
Randomized, double-blind comparison of granisetron versus granisetron plus prednisolone as antiemetic prophylaxis during multiple-day cisplatin-based chemotherapy
J Handberg, V Wessel, L Larsen, et al.
The New England Journal of Medicine
|
April 15, 1993
Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy
J Herrstedt, T Sigsgaard, M Boesgaard, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1989
The value of yearly chest X-ray in patients with stage I breast cancer
A Vestergaard, J Herrstedt, H S Thomsen, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
British Journal of Cancer
|
February 23, 2012
Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality
T L Jørgensen, J Hallas, S Friis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 10, 2016
MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update
A Molassiotis, M Aapro, J Herrstedt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy
T Sigsgaard, J Herrstedt, J Handberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)
J Herrstedt, M S Aapro, F Roila, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 2, 2000
Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy
T Sigsgaard, J Herrstedt, P Christensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2014
Bone health in cancer patients: ESMO Clinical Practice Guidelines
R Coleman, J J Body, M Aapro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 18, 1998
Corticosteroids, dopamine antagonists and other drugs
J Herrstedt, M S Aapro, J F Smyth, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 12, 1998
Randomized, double-blind comparison of granisetron versus granisetron plus prednisolone as antiemetic prophylaxis during multiple-day cisplatin-based chemotherapy
J Handberg, V Wessel, L Larsen, et al.
The New England Journal of Medicine
|
April 15, 1993
Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy
J Herrstedt, T Sigsgaard, M Boesgaard, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1989
The value of yearly chest X-ray in patients with stage I breast cancer
A Vestergaard, J Herrstedt, H S Thomsen, et al.
Page
of 7